Literature DB >> 15588067

Clinical consequences of antiphospholipid antibodies.

R H W M Derksen1, P G de Groot.   

Abstract

Antiphospholipid antibodies (aPL), notably the lupus anticoagulant and anticardiolipin antibodies, are the serological hallmarks of the antiphospholipid syndrome. Thrombosis and pregnancy complications are the most prominent clinical manifestations of this syndrome. This paper provides the clinician with guidelines for ordering and interpreting tests for aPL and discusses consequences for treatment if persistently positive tests are found.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15588067

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  2 in total

1.  Anticardiolipin antibodies in proliferative diabetic retinopathy: An additional risk factor.

Authors:  Maha Shahin; Amany M El-Diasty; Mohamed Mabed
Journal:  Saudi J Ophthalmol       Date:  2009-08-05

2.  High COVID-19 virus replication rates, the creation of antigen-antibody immune complexes and indirect haemagglutination resulting in thrombosis.

Authors:  Kevin Roe
Journal:  Transbound Emerg Dis       Date:  2020-06-03       Impact factor: 4.521

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.